Table 1 Pathway analyses between normal person and patients in different stages (top 10)
From: Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome
Source | Name | p-value | q-value Bonferroni |
|---|---|---|---|
REACTOME | Cell Cycle | 3.03E-28 | 8.61E-25 |
REACTOME | Cell Cycle, Mitotic | 7.62E-20 | 2.17E-16 |
REACTOME | Chromosome Maintenance | 1.02E-19 | 2.91E-16 |
REACTOME | Telomere Maintenance | 1.09E-19 | 3.11E-16 |
REACTOME | Deposition of New CENPA-containingNucleosomes at the Centromere | 6.22E-17 | 1.77E-13 |
REACTOME | Nucleosome assembly | 6.22E-17 | 1.77E-13 |
REACTOME | Meiotic Recombination | 2.78E-16 | 7.90E-13 |
REACTOME | RNA Polymerase I Promoter Opening | 3.36E-14 | 9.56E-11 |
REACTOME | RNA Polymerase I Transcription | 8.11E-14 | 2.31E-10 |
REACTOME | RNA Polymerase I Chain Elongation | 9.50E-14 | 2.70E-10 |